Agiliti Inc (AGTI)

$10.04

+0.01

(+0.1%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Agiliti Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 291.08M → 291.98M (in $), with an average increase of 0.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -12.70M → -5.71M (in $), with an average increase of 122.4% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 37.0% return, outperforming this stock by 75.1%

Performance

  • $10.02
    $10.07
    $10.04
    downward going graph

    0.2%

    Downside

    Day's Volatility :0.5%

    Upside

    0.3%

    downward going graph
  • $5.07
    $18.61
    $10.04
    downward going graph

    49.5%

    Downside

    52 Weeks Volatility :72.76%

    Upside

    46.05%

    downward going graph

Returns

PeriodAgiliti IncSector (Health Care)Index (Russel 2000)
3 Months
46.42%
-0.7%
0.0%
6 Months
91.05%
6.6%
0.0%
1 Year
-38.12%
3.7%
-1.5%
3 Years
-38.84%
14.0%
-21.8%

Highlights

Market Capitalization
1.4B
Book Value
$6.95
Earnings Per Share (EPS)
-0.14
Wall Street Target Price
10.0
Profit Margin
-1.65%
Operating Margin TTM
7.04%
Return On Assets TTM
1.77%
Return On Equity TTM
-2.03%
Revenue TTM
1.2B
Revenue Per Share TTM
8.72
Quarterly Revenue Growth YOY
3.6999999999999997%
Gross Profit TTM
431.0M
EBITDA
242.7M
Diluted Eps TTM
-0.14
Quarterly Earnings Growth YOY
-0.86
EPS Estimate Current Year
0.59
EPS Estimate Next Year
0.63
EPS Estimate Current Quarter
0.12
EPS Estimate Next Quarter
0.16

Analyst Recommendation

Sell
    9%Buy
    45%Hold
    45%Sell
Based on 11 Wall street analysts offering stock ratings for Agiliti Inc(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
9
Hold
5
5
4
Sell
5
5
00

Analyst Forecast

What analysts predicted

Downside of 0.4%

Current $10.04
Target $10.00

Company Financials

FY18Y/Y Change
Revenue
565.2M
-
Net Income
-31.9M
-
Net Profit Margin
-5.64%
-
FY19Y/Y Change
Revenue
613.1M
↑ 8.46%
Net Income
-31.2M
↓ 2.01%
Net Profit Margin
-5.1%
↑ 0.54%
FY20Y/Y Change
Revenue
773.3M
↑ 26.14%
Net Income
-22.2M
↓ 28.81%
Net Profit Margin
-2.88%
↑ 2.22%
FY21Y/Y Change
Revenue
1.0B
↑ 34.32%
Net Income
24.0M
↓ 207.95%
Net Profit Margin
2.31%
↑ 5.19%
FY22Y/Y Change
Revenue
1.1B
↑ 7.95%
Net Income
30.2M
↑ 25.85%
Net Profit Margin
2.69%
↑ 0.38%
FY23Y/Y Change
Revenue
1.2B
↑ 4.75%
Net Income
-19.4M
↓ 164.3%
Net Profit Margin
-1.65%
↓ 4.34%
Q3 FY22Q/Q Change
Revenue
271.2M
↓ 1.02%
Net Income
2.0M
↓ 60.96%
Net Profit Margin
0.72%
↓ 1.1%
Q4 FY22Q/Q Change
Revenue
281.7M
↑ 3.87%
Net Income
3.4M
↑ 72.78%
Net Profit Margin
1.2%
↑ 0.48%
Q1 FY23Q/Q Change
Revenue
299.9M
↑ 6.47%
Net Income
3.0M
↓ 10.62%
Net Profit Margin
1.0%
↓ 0.2%
Q2 FY23Q/Q Change
Revenue
291.1M
↓ 2.94%
Net Income
-4.0M
↓ 233.62%
Net Profit Margin
-1.38%
↓ 2.38%
Q3 FY23Q/Q Change
Revenue
291.6M
↑ 0.19%
Net Income
-12.7M
↑ 215.47%
Net Profit Margin
-4.36%
↓ 2.98%
Q4 FY23Q/Q Change
Revenue
292.0M
↑ 0.12%
Net Income
-5.7M
↓ 55.04%
Net Profit Margin
-1.96%
↑ 2.4%
FY18Y/Y Change
Total Assets
611.2M
-
Total Liabilities
745.0M
-
FY19Y/Y Change
Total Assets
1.6B
↑ 164.94%
Total Liabilities
1.2B
↑ 56.04%
FY20Y/Y Change
Total Assets
1.9B
↑ 17.53%
Total Liabilities
1.5B
↑ 25.72%
FY21Y/Y Change
Total Assets
2.5B
↑ 32.17%
Total Liabilities
1.6B
↑ 10.83%
FY22Y/Y Change
Total Assets
2.4B
↓ 2.85%
Total Liabilities
1.5B
↓ 7.53%
FY23Y/Y Change
Total Assets
2.5B
↑ 0.81%
Total Liabilities
1.5B
↑ 1.69%
Q3 FY22Q/Q Change
Total Assets
2.4B
↓ 0.89%
Total Liabilities
1.5B
↓ 1.95%
Q4 FY22Q/Q Change
Total Assets
2.4B
↑ 1.09%
Total Liabilities
1.5B
↑ 1.12%
Q1 FY23Q/Q Change
Total Assets
2.4B
↓ 0.03%
Total Liabilities
1.5B
↓ 0.1%
Q2 FY23Q/Q Change
Total Assets
2.4B
↓ 0.65%
Total Liabilities
1.5B
↓ 1.54%
Q3 FY23Q/Q Change
Total Assets
2.4B
↓ 0.35%
Total Liabilities
1.5B
↑ 0.1%
Q4 FY23Q/Q Change
Total Assets
2.5B
↑ 1.85%
Total Liabilities
1.5B
↑ 3.29%
FY18Y/Y Change
Operating Cash Flow
86.3M
↑ 22.24%
Investing Cash Flow
-51.0M
↓ 7.42%
Financing Cash Flow
-27.9M
↑ 80.37%
FY19Y/Y Change
Operating Cash Flow
70.0M
↓ 18.91%
Investing Cash Flow
-762.0M
↑ 1393.07%
Financing Cash Flow
-42.9M
↑ 53.45%
FY20Y/Y Change
Operating Cash Flow
137.9M
↑ 97.04%
Investing Cash Flow
-151.7M
↓ 80.09%
Financing Cash Flow
220.3M
↓ 613.7%
FY21Y/Y Change
Operating Cash Flow
210.3M
↑ 52.48%
Investing Cash Flow
-734.1M
↑ 383.84%
Financing Cash Flow
391.6M
↑ 77.77%
FY22Y/Y Change
Operating Cash Flow
199.8M
↓ 5.01%
Investing Cash Flow
-146.9M
↓ 80.0%
Financing Cash Flow
-121.7M
↓ 131.07%
Q3 FY22Q/Q Change
Operating Cash Flow
60.8M
↑ 78.64%
Investing Cash Flow
-21.3M
↓ 4.68%
Financing Cash Flow
-23.7M
↓ 49.71%
Q4 FY22Q/Q Change
Operating Cash Flow
37.9M
↓ 37.67%
Investing Cash Flow
-88.6M
↑ 315.06%
Financing Cash Flow
24.1M
↓ 201.32%
Q1 FY23Q/Q Change
Operating Cash Flow
54.9M
↑ 44.94%
Investing Cash Flow
-17.8M
↓ 79.87%
Financing Cash Flow
-28.2M
↓ 217.2%
Q2 FY23Q/Q Change
Operating Cash Flow
27.5M
↓ 49.86%
Investing Cash Flow
-21.3M
↑ 19.31%
Financing Cash Flow
-11.5M
↓ 59.24%
Q3 FY23Q/Q Change
Operating Cash Flow
65.7M
↑ 138.86%
Investing Cash Flow
-18.8M
↓ 11.52%
Financing Cash Flow
-25.7M
↑ 124.06%

Technicals Summary

Sell

Neutral

Buy

Agiliti Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Agiliti Inc
Agiliti Inc
-0.4%
91.05%
-38.12%
-38.84%
-38.84%
Solventum Corp
Solventum Corp
-10.64%
-10.64%
-10.64%
-10.64%
-10.64%
Veeva Systems Inc.
Veeva Systems Inc.
-12.8%
-3.39%
8.83%
-26.33%
55.83%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-5.98%
30.6%
1.83%
40.83%
40.83%
Healthequity Inc
Healthequity Inc
-3.72%
6.22%
37.05%
12.91%
23.47%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Agiliti Inc
Agiliti Inc
199.33
NA
NA
0.59
-0.02
0.02
NA
6.95
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
62.03
62.03
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
28.08
28.08
20.11
4.3
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
125.42
125.42
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Agiliti Inc
Agiliti Inc
Sell
$1.4B
-38.84%
199.33
-1.65%
Solventum Corp
Solventum Corp
NA
$11.7B
-10.64%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.3B
55.83%
62.03
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$39.0B
40.83%
28.08
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
23.47%
125.42
5.57%

Institutional Holdings

  • Lee Thomas H Partners LP

    72.22%

  • BlackRock Inc

    3.98%

  • JPMorgan Chase & Co

    3.80%

  • T. Rowe Price Investment Management,Inc.

    3.50%

  • Vanguard Group Inc

    2.76%

  • HHG PLC

    2.26%

Company Information

agiliti is a company of 3,000 passionate equipment management experts who believe every interaction has the power to change a life. we’ve built a brand that’s dedicated to optimizing clinical outcomes while relentlessly improving economic outcomes for our customers.

Organization
Agiliti Inc
Employees
5800
CEO
Mr. Thomas J. Leonard
Industry
Healthcare

Discover More

FAQs